Fortress Biotech, Inc. (FBIO): Price and Financial Metrics

FBIO POWR Grades

• Sentiment is the dimension where FBIO ranks best; there it ranks ahead of 78.5% of US stocks.
• FBIO's strongest trending metric is Momentum; it's been moving down over the last 177 days.
• FBIO ranks lowest in Quality; there it ranks in the 2nd percentile.

FBIO Stock Summary

• With a price/sales ratio of 0.18, FORTRESS BIOTECH INC has a higher such ratio than just 6.61% of stocks in our set.
• The volatility of FORTRESS BIOTECH INC's share price is greater than that of 98.32% US stocks with at least 200 days of trading history.
• FORTRESS BIOTECH INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 181.44%, greater than the shareholder yield of 98.64% of stocks in our set.
• Stocks that are quantitatively similar to FBIO, based on their financial statements, market capitalization, and price volatility, are PXLW, TDUP, LUMO, CYCN, and BTAI.
• FBIO's SEC filings can be seen here. And to visit FORTRESS BIOTECH INC's official web site, go to www.fortressbiotech.com.

FBIO Valuation Summary

• In comparison to the median Healthcare stock, FBIO's EV/EBIT ratio is 101.02% lower, now standing at -0.1.
• Over the past 146 months, FBIO's EV/EBIT ratio has gone up 6.

Below are key valuation metrics over time for FBIO.

FBIO Growth Metrics

Its 4 year cash and equivalents growth rate is now at 1.75%.
• Its year over year revenue growth rate is now at 83.27%.
• Its 2 year net income to common stockholders growth rate is now at -33.36%.

FBIO's revenue has moved up $24,961,000 over the prior 15 months.

The table below shows FBIO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	77.615	-170.253	-91.192
2022-06-30	82.172	-148.676	-89.462
2022-03-31	81.129	-141.712	-71.641
2021-12-31	68.791	-116.54	-64.703
2021-09-30	64.264	-98.33	-38.433
2021-06-30	52.654	-100.526	-33.199

FBIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• FBIO has a Quality Grade of D, ranking ahead of 14.81% of graded US stocks.
• FBIO's asset turnover comes in at 0.147 -- ranking 224th of 682 Pharmaceutical Products stocks.
• MGNX, MTEX, and MNKKQ are the stocks whose asset turnover ratios are most correlated with FBIO.

The table below shows FBIO's key quality metrics over time.